Inozyme Pharma Insiders Bank 37% Return From Rock Bottom Secondary Offering

Inozyme Pharma (NASDAQ:INZY) has been experiencing high levels of insider accumulation, with five net insiders acquiring shares over the last 90 days.

Related Keywords

China ,Zhang Hui ,Anhui ,Chinese ,Eun Yang ,Kurt Gunter ,Darkostojanovic Pixabay ,Suji Jeong ,Venture Partners Fund ,Nasdaq ,Inozyme Pharma Insiders Bank ,Hc Wainwright Co Analyst Edward White ,Return From Rock Bottom Secondary Offering ,Manager Profile ,Zhang Hui Of China ,Southern Asset ,Activist Investing Case ,San Francisco Based ,Longitude Capital ,Kurt Gunter Chief Medical ,Chief Medical Officer ,